Durect Corp

NASDAQ:DRRX

0.67

0.00 (+0.02%)

4:26:53 PM EDT: $0.65 -0.02 (-2.51%)

Market Cap (Intraday)	20.70M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.31 Million
Adjusted EPS	-$0.12

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Durect Corp Stock, NASDAQ:DRRX

10240 Bubb Road, Cupertino, California 95014-4166

United States of America

Phone: +1.408.777.1417

Number of Employees: 58

http://www.durect.com

Description

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.